With DARPA Deadlines and a $3.1B War Chest, IonQ's Near-Term Stock Pain Masks Long-Term Ambition

IonQ shares fell 5% on profit-taking but institutional ownership climbed to 41% as cash reserves hit $3.1B and backlog surged 554% YoY.

The quantum computing sector took a collective hit on May 18, with IonQ's shares sliding 5.08% to close at $49.31 and slipping further to $48.38 in after-hours trading. The pullback was hardly an isolated event—D-Wave Quantum tumbled 8%, while Rigetti Computing and Quantum Computing Inc. each shed roughly 10%. Market participants attributed the moves to profit-taking after a blistering rally that had carried IonQ to a high of $84.64, and the technical picture confirmed the cooling: the 14-day relative strength index fell from an overbought reading of 77.95 to 58.58.

Yet beneath the surface, institutional money was moving the other way. The Bessemer Group increased its stake by 6.5%, now holding 214,390 shares worth roughly $9.6 million. The Royal Bank of Canada and UBS Asset Management also added to their positions, pushing aggregate institutional ownership to 41.42% of outstanding shares. The buying suggests that large investors see the dip as an opportunity rather than a change in the company's fundamental trajectory.

That trajectory is underpinned by numbers that few quantum peers can match. IonQ ended March with a cash balance of $3.1 billion, and its order backlog swelled to $470 million—an eye-popping 554% increase year over year. CFO Inder Singh, speaking at the J.P. Morgan Global Technology, Media and Communications Conference on the same day the stock dropped, highlighted how revenue had climbed from near zero to $130 million in 2025. The first quarter of 2026 alone delivered $64.67 million in sales, up 755% from the prior year, and management raised its full-year revenue guidance to a range of $260 million to $270 million. For the second quarter, IonQ expects between $65 million and $68 million.

The growth story is clear, but so is the profitability gap. Analysts project a loss per share of $0.341 for the current year, and the market remains wary of unprofitable tech names amid rising bond yields. That tension shows in the analyst community: Wedbush rates the stock "Outperform" with a $75 target, while Morgan Stanley is far more cautious at "Equalweight" and a $48.50 target. Broker consensus sits at 11 buy or strong-buy recommendations, with price targets clustering between $66 and $69.

IonQ is also laying the groundwork for its future competitive edge. Shareholders have approved the acquisition of SkyWater Technology, a move that will give IonQ its own fabrication capability for ion-trap chips—a critical piece of the company's plan to build a 10,000-qubit architecture. First chip samples from the new production lines have already arrived. Separately, IonQ is constructing a fully operational quantum computer in Colorado, backed by CHIPS Zone incentives, and is participating in DARPA's HARQ program, with milestones in quantum cryptography set for 2028–2029 and a target for a fault-tolerant system by 2030.

The next major checkpoint for investors comes on August 12, when IonQ reports second-quarter earnings. Until then, the stock will likely swing with the mood around high-growth tech. A sustained rise in bond yields would add pressure, while better-than-expected revenue or progress on cost control could reinforce the institutional vote of confidence seen in recent buying.